Drug Profile

IZN 6D4

Alternative Names: IZN-6D4

Latest Information Update: 24 Dec 2019

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Izun Pharma
Class Antiulcers; Herbal medicines
Mechanism of Action Undefined mechanism

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Discontinued Diabetic foot ulcer

Most Recent Events

24 Dec 2019 Discontinued - Phase-II for Diabetic foot ulcer in Israel (Topical) (Izun Pharma website, December 2019)
13 Oct 2015 Efficacy data from a phase-II trial in Diabetic foot ulcer released by Izun Pharma
17 Aug 2015 Phase-II development for Diabetic foot ulcer is ongoing in Israel

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com